Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaojitongbian is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Affiliated Hospital of Nanjing University of Chinese Medicine (also known as Jiangsu Provincial Hospital of Traditional Chinese Medicine). It is primarily indicated for the treatment of functional constipation, particularly cases characterized by heat accumulation and qi stagnation according to TCM diagnostic principles. The formulation typically consists of herbal extracts including *Rheum palmatum* (Dahuang), *Magnolia officinalis* (Houpo), and *Aurantii Fructus Immaturus* (Zhishi). Its mechanism of action involves stimulating gastrointestinal motility and increasing intestinal fluid secretion, which facilitates bowel movements. As a hospital-made preparation (院内制剂), it is approved for clinical use within the developing institution's healthcare network in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaojitongbian.